Table 1.
Comparison of clinical data between the two groups
| Experimental group (n=50) | Control group (n=40) | t/χ2 | P | |
|---|---|---|---|---|
| Age (years) | 45.1±12.3 | 42.5±11.47 | 2.25 | 0.65 |
| Sex | 1.156 | 0.64 | ||
| Male (n%) | 29 (58.0%) | 24 (60.0%) | ||
| Female (n%) | 21 (42.0%) | 16 (40%) | ||
| BMI | 19.4±1.66 | 19.1±1.76 | 5.74 | 0.21 |
| Hemoglobin (g/L) | 120±145 | 123±148 | 5.64 | 0.22 |
| Platelet count (×10/L) | 110±152 | 117±203 | 7.43 | 0.13 |
| Creatinine (μ mol/L) | 51±68 | 52±71 | 5.72 | 0.31 |
| PT (sec) | 13.4±15.2 | 13±14.2 | 2.43 | 0.62 |
| INR | 1.02±1.21 | 0.99±1.11 | 3.12 | 0.609 |
| Smoking | 16 (32.0%) | 16 (40.0%) | 2.71 | 0.35 |
| Cerebral infarction | 7 (14.0%) | 7 (17.5%) | 2.96 | 0.33 |
| Hypertension | 17 (34.0%) | 17 (42.5%) | 1.79 | 0.26 |
| Diabetes | 10 (20.0%) | 11 (27.5%) | 1.29 | 0.19 |
| Coronary heart disease | 4 (8.0%) | 6 (15.0%) | 2.48 | 0.32 |
Note: Significant difference defined as P<0.05.